Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Byerley

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Clinical Psychopharmacology|August 1, 1985
Depression and serotonin metabolism: rationale for neurotransmitter precursor treatmentW F Byerley, S C Risch
Schizophrenia Research|May 1, 1989
Strategies for linkage studies in schizophreniaC D Mellon, W F Byerley
Psychiatric Genetics|January 1, 1995
1995 Park City Molecular Psychiatry Conference, 5-8 February 1995, Park City, UtahJ I Nurnberger, W F Byerley
The Journal of Clinical Psychiatry|November 1, 1987
Treatment of seasonal affective disorder with morning lightW F Byerley, J Brown, B Lebegue
Psychiatry Research|November 1, 1989
The introductory placebo washout: a retrospective evaluationF W Reimherr, M F Ward, W F Byerley
Journal of Clinical Psychopharmacology|June 1, 1987
5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effectsW F Byerley, L L Judd, F W Reimherr, et al.
Journal of Clinical Psychopharmacology|April 1, 1988
Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depressionW F Byerley, F W Reimherr, D R Wood, et al.
American Journal of Medical Genetics|February 16, 1996
Genotype-to-phenotype analysis: search for clinical characteristics of a missense change in the GABAA-beta 1 receptor geneJ L Sobell, D C Sigurdson, L L Heston, et al.
Psychiatric Genetics|September 20, 2000
Mutation screening of a neutral amino acid transporter, ASCT1, and its potential role in schizophreniaP J Bennett, M Hoff, J Rosenthal, et al.
Psychopharmacology|January 1, 1988
Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetineW F Byerley, E J McConnell, R T McCabe, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Clinical Psychopharmacology|August 1, 1985
Depression and serotonin metabolism: rationale for neurotransmitter precursor treatmentW F Byerley, S C Risch
Schizophrenia Research|May 1, 1989
Strategies for linkage studies in schizophreniaC D Mellon, W F Byerley
Psychiatric Genetics|January 1, 1995
1995 Park City Molecular Psychiatry Conference, 5-8 February 1995, Park City, UtahJ I Nurnberger, W F Byerley
The Journal of Clinical Psychiatry|November 1, 1987
Treatment of seasonal affective disorder with morning lightW F Byerley, J Brown, B Lebegue
Psychiatry Research|November 1, 1989
The introductory placebo washout: a retrospective evaluationF W Reimherr, M F Ward, W F Byerley
Journal of Clinical Psychopharmacology|June 1, 1987
5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effectsW F Byerley, L L Judd, F W Reimherr, et al.
Journal of Clinical Psychopharmacology|April 1, 1988
Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depressionW F Byerley, F W Reimherr, D R Wood, et al.
American Journal of Medical Genetics|February 16, 1996
Genotype-to-phenotype analysis: search for clinical characteristics of a missense change in the GABAA-beta 1 receptor geneJ L Sobell, D C Sigurdson, L L Heston, et al.
Psychiatric Genetics|September 20, 2000
Mutation screening of a neutral amino acid transporter, ASCT1, and its potential role in schizophreniaP J Bennett, M Hoff, J Rosenthal, et al.
Psychopharmacology|January 1, 1988
Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetineW F Byerley, E J McConnell, R T McCabe, et al.
Pageof 2